Serina’s new Parkinson’s therapy clears first safety hurdle
Slow-release apomorphine patch just passed first blinded review, and company says the early numbers already look like what it hoped for. There’s a moment in advanced Parkinson’s disease that doctors call “OFF” time. It’s when the pills stop working mid-cycle, and a person who was walking and talking
<p>Slow-release apomorphine patch just passed first blinded review, and company says the early numbers already look like what it hoped for. There’s a moment in advanced Parkinson’s disease that doctors call “OFF” time. It’s when the pills stop working mid-cycle, and a person who was walking and talking</p>